Cryo-Cell International, Inc.
CCEL · AMEX
Market closed$3.67$0.190000 (+5.46%)After hours $3.46 · -5.72%
Key statistics
Previous close$3.48
Open$3.54
Day high$3.80
Day low$3.46
52-week high$5.43
52-week low$2.72
Market cap29.59M
Volume17.65K
Average volume8.91K
P/E ratio-11.12
Forward P/E—
EPS-0.33
Dividend yield0.00%
Market context
Why it moved
CCEL shares moved higher today likely driven by renewed investor interest and small-cap momentum buying, as no specific negative catalysts were present and low-volume trading amplified the upward price swing.
What is happening
Recent company-specific developments and publisher coverage.
Moomoo · July 16, 2026$CCEL ($CCEL) Releases Q2 2026 EarningsTradingView · July 15, 2026CRYO CELL INTERNATIONAL INC Q2 2026: Revenue $7.78M (Q2), $15.46M (6 months) — 10-Q Summaryscanx.trade · July 15, 2026Cryo-Cell net income rises 56% to $555,000 in Q2www.marketscreener.com · July 15, 2026Cryo-Cell International, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2026Investing.com · July 15, 2026CryoCell International earnings beat by $0.09, revenue topped estimatesStock Titan · July 15, 2026Cryo-Cell’s Public Bank Has Provided Cord Blood for More Than 900 TransplantsBusiness Wire · July 15, 2026Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2026 Financial ResultsStock Titan · July 7, 2026Camac Fund holds 6.8% Cryo-Cell (CCEL) stake and may engage board Benzinga · July 15, 2026Cryo-Cell International Q2 EPS $0.07 Up From $0.04 YoY, Sales $7.800M Down From $7.900M YoY Mt Newswire · May 8, 2026Cryo-Cell Gets NYSE American Approval for Compliance Plan Benzinga · April 14, 2026Cryo-Cell International Q1 EPS $0.01 Beats $(0.10) Estimate, Sales $7.683M Beat $7.631M Estimate Benzinga · February 27, 2026Cryo-Cell International Q4 EPS $(0.13) Misses $(0.11) Estimate, Sales $7.843M Beat $7.731M Estimate